GO Term | Evidence Code | PMID |
---|---|---|
cellular response to luteinizing hormone stimulus | ||
trabecular meshwork development | ||
cellular response to tumor necrosis factor | ||
response to dexamethasone | ||
negative regulation of cell population proliferation |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:5854 | silent myocardial infarction | |
DOID:5998 | microglandular adenosis | |
DOID:6000 | congestive heart failure | |
DOID:6114 | cerebral convexity meningioma | |
DOID:615 | leukopenia | |
DOID:6204 | follicular adenoma | |
DOID:6263 | inflammatory breast carcinoma | |
DOID:6548 | angiomatous meningioma | |
DOID:657 | adenoma | |
DOID:6726 | fibrillary astrocytoma |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000486 | Strabismus |
HP:0000501 | Glaucoma |
HP:0000505 | Visual impairment |
HP:0000523 | Subcapsular cataract |
HP:0000525 | Abnormality iris morphology |
HP:0000541 | Retinal detachment |
HP:0000557 | Buphthalmos |
HP:0000572 | Visual loss |
HP:0000587 | Abnormal optic nerve morphology |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
107586077 | SINGR28061 | ||
106825888 | EQUAS08935 | ||
105292959 | PTEVA08344 | ||
115055310 | ECHNA09814 | ||
115399571 | SALFA52884 | ||
105507461 | COLAP05091 | ||
105818018 | PROCO05798 | ||
109100547 | CYPCA64164 | ||
109100558 | CYPCA80681 | ||
103725278 | NANGA19347 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024